91 related articles for article (PubMed ID: 224984)
1. An approach to measuring the in vivo transformation of glycerol to a very low density lipoprotein triglyceride.
Kallai-Sanfaçon MA; Norwich KH; Steiner G
Can J Biochem; 1979 Jun; 57(6):613-7. PubMed ID: 224984
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of VLDL triglyceride production by the liver and intestine.
Steiner G; Ilse WK
Can J Biochem; 1981 Aug; 59(8):637-41. PubMed ID: 7296346
[TBL] [Abstract][Full Text] [Related]
3. VLDL-triglyceride production after alcohol ingestion, studied using [2-13C1] glycerol.
Siler SQ; Neese RA; Parks EJ; Hellerstein MK
J Lipid Res; 1998 Dec; 39(12):2319-28. PubMed ID: 9831620
[TBL] [Abstract][Full Text] [Related]
4. Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production.
Wang W; Basinger A; Neese RA; Shane B; Myong SA; Christiansen M; Hellerstein MK
Am J Physiol Endocrinol Metab; 2001 Mar; 280(3):E540-7. PubMed ID: 11171611
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular triglyceride synthesis and transfer to lipid droplets and nascent very low density lipoproteins.
Chao FF; Stiers DL; Ontko JA
J Lipid Res; 1986 Nov; 27(11):1174-81. PubMed ID: 3559383
[TBL] [Abstract][Full Text] [Related]
6. Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes.
Durrington PN; Newton RS; Weinstein DB; Steinberg D
J Clin Invest; 1982 Jul; 70(1):63-73. PubMed ID: 7045162
[TBL] [Abstract][Full Text] [Related]
7. Sources of blood glycerol during fasting.
Jensen MD; Chandramouli V; Schumann WC; Ekberg K; Previs SF; Gupta S; Landau BR
Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E998-1004. PubMed ID: 11595656
[TBL] [Abstract][Full Text] [Related]
8. Estimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans.
Kalhan SC; Bugianesi E; McCullough AJ; Hanson RW; Kelley DE
Metabolism; 2008 Mar; 57(3):305-12. PubMed ID: 18249200
[TBL] [Abstract][Full Text] [Related]
9. Measuring very low density lipoprotein-triglyceride kinetics in man in vivo: how different the various methods really are.
Magkos F; Sidossis LS
Curr Opin Clin Nutr Metab Care; 2004 Sep; 7(5):547-55. PubMed ID: 15295275
[TBL] [Abstract][Full Text] [Related]
10. Endogenous triglyceride turnover in liver and plasma of the dog.
Gross RC; Eigenbrodt EH; Farquhar JW
J Lipid Res; 1967 Mar; 8(2):114-25. PubMed ID: 14564717
[TBL] [Abstract][Full Text] [Related]
11. Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins.
Arad Y; Ramakrishnan R; Ginsberg HN
Metabolism; 1992 May; 41(5):487-93. PubMed ID: 1588827
[TBL] [Abstract][Full Text] [Related]
12. Turnover of plasma total and very low density lipoprotein triglyceride in man.
Kekki M; Nikkilä EA
Scand J Clin Lab Invest; 1975 Mar; 35(2):171-9. PubMed ID: 167428
[TBL] [Abstract][Full Text] [Related]
13. Suppression by diets rich in fish oil of very low density lipoprotein production in man.
Nestel PJ; Connor WE; Reardon MF; Connor S; Wong S; Boston R
J Clin Invest; 1984 Jul; 74(1):82-9. PubMed ID: 6736254
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
15. Treatment with artificial beta-cell decreases very-low-density lipoprotein triglyceride synthesis in type I diabetes.
Dunn FL; Carroll PB; Beltz WF
Diabetes; 1987 May; 36(5):661-6. PubMed ID: 3552799
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein cholesterol and triglyceride concentrations associated with dog body condition score; effect of recommended fasting duration on sample concentrations in Japanese private clinics.
Usui S; Yasuda H; Koketsu Y
J Vet Med Sci; 2015 Sep; 77(9):1063-9. PubMed ID: 25866404
[TBL] [Abstract][Full Text] [Related]
17. Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects.
Zech LA; Grundy SM; Steinberg D; Berman M
J Clin Invest; 1979 Jun; 63(6):1262-73. PubMed ID: 221537
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of Troglitazone in patients with diet-controlled type 2 diabetes.
Robinson AC; Jeffs JA; Gray RG; Bannister PA; Mather H; Gallagher JJ; Robinson S; Nattrass M; Venkatesan S; Halliday D; Johnston DG
Eur J Clin Invest; 2004 Jan; 34(1):29-36. PubMed ID: 14984435
[TBL] [Abstract][Full Text] [Related]
19. Hypotriglyceridemic effects of levonorgestrel in rats.
Khokha R; Wolfe BM
Atherosclerosis; 1984 Sep; 52(3):329-38. PubMed ID: 6437417
[TBL] [Abstract][Full Text] [Related]
20. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
Kissebah AH; Alfarsi S; Adams PW
Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
